Introduction {#Sec1}
============

Osteocytes, which are embedded in the bone matrix, establish an extensive intracellular and extracellular communication system via gap-junction-coupled cell processes and canaliculi through which cell processes pass throughout the bone and the communication system is extended to osteoblasts on the bone surface (Marks and Odgren [@CR32]). Bone tissue is able to adapt its mass and three-dimensional structure to the prevailing mechanical usage to achieve higher load-bearing efficiency (Wolff [@CR65]). The lacunocanalicular network formed by osteocytes is thought to be an ideal mechanosensory system and suitable for mechanotransduction by which mechanical energy is converted into electrical and/or biochemical signals (Burger and Klein-Nulend [@CR6]; Martin [@CR33]; Ehrlich and Lanyon [@CR12]; Knothe Tate [@CR20]; Bonewald and Johnson [@CR5]; Noble [@CR40]). However, the special anatomic features of osteocytes, which are isolated in lacunae but are three-dimensionally connected to each other, make it difficult to study their function. This review focuses on the mechanism of osteocyte apoptosis-induced bone resorption and functions of the osteocyte network in the regulation of bone mass under physiological and unloaded conditions.

Osteocyte death and bone remodeling {#Sec2}
===================================

Osteocyte death occurs during aging, after menopause, at unloading and under pathological conditions such as microcracks and the death of osteocytes is closely coupled with bone resorption (Noble and Reeve [@CR41]; Cardoso et al. [@CR8]; Emerton et al. [@CR13]). Cells die mainly through one of three pathways, i.e., apoptosis, autophagic cell death and necrosis, under physiological and pathological conditions, although dying cells can share apoptotic and autophagic features (Bursch [@CR7]; Fig. [1](#Fig1){ref-type="fig"}). If cells die through apoptosis or autophagy, death is completed with the removal of the cells through engulfment by scavengers. In these cases, the cells are quietly removed without inflammation, because the integrity of the cytoplasmic membranes is maintained when phagocytosis occurs. In contrast, strong insults cause bioenergetic failure and rapid loss of the integrity of the cytoplasmic membrane, both of which are core events of necrosis. Necrosis leads to the rupture of the cytoplasmic membrane and most of the intracellular content is released into the extracellular environment. The released intracellular content encompasses immunostimulatory molecules including the so-called damage-associated molecular pattern molecules, such as S100 family molecules, high-mobility group box 1 protein, purine metabolites, heat-shock proteins and uric acid (Lotze and Tracey [@CR29]; Zong and Thompson [@CR72]). The release of the immunostimulatory molecules actively recruits a defensive or a reparative response to the damaged regions. If cells at the terminal phase of apoptosis or autophagic cell death are not engulfed by phagocytes, a transition to necrosis ensues and the cells are eliminated by cell disruption. This process is called secondary necrosis (Majno and Joris [@CR31]; Silva et al. [@CR55]). As scavengers cannot reach osteocytes, any type of osteocyte death will end in the rupture of the cytoplasmic membrane. After cell rupture, immunostimulatory molecules are released from lacunae through canaliculi to the bone surface and vascular channels and facilitate the recruitment and activation of macrophages, thereby promoting the production of proinflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukin (IL)-6 and IL-1 (Lotze and Tracey [@CR29]). Further, IL-6 and IL-1 induce receptor activator of nuclear factor κ-B ligand (Rankl) expression, which is essential for osteoclastogenesis (Yasuda et al. [@CR67]; Kong et al. [@CR22]; O'Brien [@CR42]). As TNF-α, IL-6 and IL-1 are the most important proinflammatory cytokines triggering inflammatory bone loss (Firestein [@CR14]), primary and secondary osteocyte necrosis could lead to the enhancement of osteoclastogenesis and bone resorption, which comprise a repair process in bone (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Osteocyte death and bone resorption. Cells die mainly through one of three pathways: apoptosis, autophagic cell death and necrosis. As osteocytes at the terminal phase of apoptosis or autophagic cell death are not engulfed by phagocytes, the process of secondary necrosis ensues. After cell rupture, immunostimulatory molecules including high-mobility group box 1 (*HMGB1*), S100, heat shock protein (*HSP*), adenosine triphosphate (*ATP*) and uric acid are released from lacunae through canaliculi to the bone surface and vascular channels, where they facilitate the recruitment and activation of macrophages, thereby promoting the production of proinflammatory cytokines, including tumor necrosis factor-α (*TNF-α*), interleukin 6 (*IL-6*) and interleukin 1 (*IL-1*), which induce osteoclastogenesis and bone resorption. Apoptotic osteocytes release osteoclastogenesis-promoting factors, including soluble receptor activator of nuclear factor κ-B ligand (*sRankl*), IL-6 and soluble IL-6 receptor (*sIL-6R*) and induce TNF-α expression in osteoclast precursors in vitro

Apoptotic osteocytes show enhancement of osteoclastogenesis in vitro (Kogianni et al. [@CR21]; Al-Dujaili et al. [@CR1]; Cheung et al. [@CR10]; Shandala et al. [@CR54]). Addition of apoptotic bodies from osteocytes but not osteoblasts induces osteoclastogenesis through the induction of TNF-α production by mononuclear osteoclast precursors (Kogianni et al. [@CR21]). Conditioned medium from apoptotic osteocytic cell line MLO-Y4 contains more soluble Rankl than that from non-apoptotic MLO-Y4 cells and induces osteoclastogenesis (Al-Dujaili et al. [@CR1]). Methotrexate (MTX)-induced apoptosis of MLO-Y4 cells increases IL-6 and IL-11 expression and the conditioned media promote osteoclastogenesis (Shandala et al. [@CR54]). Further, apoptotic MLO-Y4-conditioned media promote osteoclast precursor adhesion to endothelial cells via intercellular adhesion molecule 1 (ICAM-1), probably through the induction of IL-6 and soluble IL-6 receptor (Cheung et al. [@CR10]). Therefore, apoptotic osteocytes can upregulate the expression of osteoclastogenesis-promoting factors (Fig. [1](#Fig1){ref-type="fig"}).

Another special feature of osteocyte death is the sustained detection of degraded DNA by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL; Weinstein et al. [@CR63]; Moriishi et al. [@CR36], [@CR35]). This indicates that a part of the DNA degraded during the process of apoptosis is retained in the lacunae, even after secondary necrosis. Even during primary necrosis, randomly degraded DNA retained in the lacunae can be detected by TUNEL. The reactivity of TUNEL in the lacunae is retained until the bone, including the lacunae, is resorbed.

Functions of osteocytes in bone resorption {#Sec3}
==========================================

As the death of osteocytes induces bone resorption, the physiological function of osteocytes has been considered to be the inhibition of bone resorption (Gu et al. [@CR16]; Tatsumi et al. [@CR56]). A typical example is osteocyte ablation by diphtheria toxin (Tatsumi et al. [@CR56]). Transgenic mice expressing diphtheria toxin receptor under the control of the *dentin matrix protein 1* (*Dmp1*) promoter show enhanced bone resorption resulting in severe osteoporosis after the injection of diphtheria toxin. Dmp1 expression begins in osteoblasts when they are about to be embedded into the bone matrix and Dmp1 expression is high in immature osteocytes but decreases during osteocyte maturation (Toyosawa et al. [@CR57]; Xiong et al. [@CR66]). After primary or secondary necrosis caused by diphtheria toxin, the intracellular content of osteocytes is released from the lacunae onto the bone surface and vascular channels and promotes osteoclastogenesis as a process of repair (Fig. [1](#Fig1){ref-type="fig"}). This seems to be the case, because *Rankl* is highly induced after the injection of diphtheria toxin (Tatsumi et al. [@CR56]). Although osteocyte death causes bone resorption, whether live osteocytes inhibit bone resorption remains unclear.

Gja1 (connexin 43) is the major gap junction protein and plays important roles in osteogenesis and osteoblast function (Lecanda et al. [@CR24]; Chung et al. [@CR11]; Watkins et al. [@CR62]). Targeted deletion of *Gja1* in osteocytes results in the disruption of the intercellular communication of osteocytes through gap junctions, while retaining communication through the canalicular network (Bivi et al. [@CR4]). In this mouse model, osteocyte apoptosis is increased, the osteoclast number and surface are increased at the endocortical surface and the marrow cavity is enlarged. This indicates that osteocyte apoptosis in conditional *Gja1* knockout mice could induce bone resorption, probably because the intracellular content of dead osteocytes could be released through the intact canalicular network and trigger osteoclastogenesis and bone resorption (Fig. [1](#Fig1){ref-type="fig"}). The abundance of osteoclast precursor cells and immune cells in bone marrow should facilitate bone resorption at the endocortical surface after osteocyte apoptosis.

Another model of dysfunction of the osteocyte network is the osteoblast-specific *BCL2* transgenic mouse. *BCL2* transgenic mice have a reduced number of osteocyte processes probably because of the function of BCL2 to alter cytoskeletal organization; the osteocytes gradually die by apoptosis and the frequency of TUNEL-positive lacunae reaches 80% at 4 months of age (Moriishi et al. [@CR36], [@CR35]). However, bone resorption is not induced by osteocyte apoptosis in *BCL2* transgenic mice and both the intracellular and extracellular osteocyte networks are disrupted at 4 months of age by the reduced number of canaliculi and the accumulation of TUNEL-positive lacunae. The absence of enhanced bone resorption in *BCL2* transgenic mice seems to be attributable to the failure of canalicular (extracellular) network formation, which interrupts the release of the intracellular content of dead osteocytes onto the bone surface and into vascular channels. Contrary to many previous observations that osteocyte apoptosis enhances bone resorption, the number of osteoclasts and bone resorption are reduced in *BCL2* transgenic mice. Interestingly, the number of osteoclasts is reduced on the endocortical surface but not on the periosteal surface in cortical bone, suggesting that the osteocyte network plays a major role in regulating osteoclastogenesis on the endocortical surface of cortical bone. These findings indicate that the disruption of both the intercellular and extracellular communication systems of osteocytes suppresses osteoclastogenesis and bone resorption. As *BCL2* overexpression in osteoblasts has no effect on osteoclastogenesis and bone resorption (Moriishi et al. [@CR36], [@CR35]), we conclude that the osteocyte network enhances osteoclastogenesis and bone resorption under physiological conditions (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Regulation of bone mass by the osteocyte network. **a** Regulation of bone mass under physiological conditions. The osteocyte network mildly stimulates osteoclastogenesis and bone resorption and mildly inhibits osteoblast function and bone formation. Rankl expression in osteoblasts and sclerostin (*Sost*) expression in osteocytes are, at least in part, responsible for the enhanced bone resorption and suppressed bone formation, respectively. Both Rankl and osteoprotegerin (*Opg*) are highly expressed in osteocytes and Opg seems to be trapped by Rankl on the surface of osteocytes. sRankl secreted by osteocytes might be involved in the regulation of osteoclastogenesis (*dashed arrow*). **b** Regulation of bone mass in the unloaded condition. The osteocyte network strongly stimulates osteoclastogenesis and bone resorption and strongly inhibits osteoblast function and bone formation. The osteocyte network enhances Rankl expression in osteoblasts and Sost expression in osteocytes in the unloaded condition. The signals from osteocytes that stimulate Rankl expression in osteoblasts remain to be identified. Upregulation of Rankl in osteocytes in the unloaded condition is controversial. In **a**, **b**, the *thickness* of the *lines* and *arrows* reflects the strength of the effects and the *height* of the osteoblasts reflect their activities

Osteocytes highly express *Rankl* compared with osteoblasts (Nakashima et al. [@CR38]; Xiong et al. [@CR66]; Moriishi et al. [@CR35]). Conditional *Rankl* deletion by using *Dmp1* Cre transgenic mice results in increased bone mass (Nakashima et al. [@CR38]; Xiong et al. [@CR66]). Rankl is produced as a membrane-bound or soluble form, although the membrane-bound form is much more efficient in terms of osteoclast formation than the soluble form (Lum et al. [@CR30]; Nakashima et al. [@CR39]; Ikeda et al. [@CR19]; Hikita et al. [@CR18]). The production of soluble Rankl (sRankl) in MLO-Y4 cells is controversial; one study has shown that the conditioned media from MLO-Y4 cells support osteoclastogenesis, whereas another has demonstrated that conditioned media fail to support osteoclastogenesis (Zhao et al. [@CR69]; Al-Dujaili et al. [@CR1]). As sRankl is detected in the circulatory system of humans (Schett et al. [@CR51]; Trofimov et al. [@CR58]; Rogers and Eastell [@CR49]; Ziegler et al. [@CR71]), the physiological importance of sRankl produced by osteocytes needs to be investigated, because the direct interaction of osteocytes with osteoclasts and their precursors will be limited (Fig. [2](#Fig2){ref-type="fig"}). The secreted factor osteoprotegerin (Opg), which is produced in osteocytes, might also be released onto the bone surface and vascular channel through canaliculi without being trapped by the Rankl on the surface of osteocytes in the *Rankl* conditional knockout mice, because *Opg* is also highly expressed in osteocytes (Moriishi et al. [@CR35]). Under physiological conditions, most of the Opg produced by osteocytes seem to be trapped by Rankl on the surface of osteocytes, because the osteocyte network enhances osteoclastogenesis under physiological conditions (Moriishi et al. [@CR35]; Fig. [2](#Fig2){ref-type="fig"}).

Functions of osteocytes in bone formation {#Sec4}
=========================================

The function of osteocytes in bone formation under physiological conditions has been controversial. Ablation of osteocytes by diphtheria toxin severely reduces bone formation, indicating that osteocyte death also affects bone formation. Reduced bone formation also seems to be caused by secondary necrosis-induced inflammation, because osteoblast maturation is severely inhibited in diphtheria toxin receptor transgenic mice (Tatsumi et al. [@CR56]). In contrast, osteocyte density is negatively correlated with bone formation and both the empty lacunar density and periosteal bone apposition increase with age, suggesting a linkage between the two phenomena (Lazenby [@CR23]; Qiu et al. [@CR46]; Metz et al. [@CR34]; Russo et al. [@CR50]; Hedgecock et al. [@CR17]). Mice carrying a targeted mutation of *Col1a1*, encoding a collagenase-resistant form of type I collagen, exhibit osteocyte apoptosis and increased bone formation (Zhao et al. [@CR70]). Further, enhanced bone formation at the periosteal and endocortical surfaces is localized in the area in which viable osteocytes are lost in osteocyte-specific *Gja1* knockout mice (Bivi et al. [@CR4]). In a study of *BCL2* transgenic mice at 4 months of age, bone formation in both trabecular and cortical bones was enhanced when the osteocyte network was disrupted, although the contribution of *BCL2* overexpression in osteoblasts to bone formation could not be completely excluded (Moriishi et al. [@CR35]). Combining the findings from these mouse models with the histological observations showing the inverse linkage between osteocyte density and bone formation, we conclude that the osteocyte network suppresses bone formation under physiological conditions (Fig. [2](#Fig2){ref-type="fig"}).

Sost (sclerostin) is specifically expressed in osteocytes and inhibits osteoblast function and bone formation by antagonizing canonical Wnt signaling through binding to Wnt co-receptor low density lipoprotein receptor-related protein (LRP) 5 and LRP6, and bone formation is enhanced in trabecular bone and on the endocortical and periosteal surfaces of cortical bone in *Sost*-deficient mice (Winkler et al. [@CR64]; van Bezooijen et al. [@CR59], [@CR60]; Bellido et al. [@CR3]; Li et al. [@CR26], [@CR25]; Poole et al. [@CR43]; Semenov et al. [@CR53]). Further, osteocyte-specific deletion of the parathyroid hormone (PTH) receptor increases Sost expression and the specific expression of constitutively active PTH receptor in osteocytes reduces it, indicating the involvement of Sost in the anabolic action of PTH (Powell et al. [@CR44]; Rhee et al. [@CR47]). Therefore, Sost is a major negative regulator of osteoblast differentiation and function produced by osteocytes. As the dissemination of Sost through canaliculi is impaired in *BCL2* transgenic mice, impaired secretion to the bone surface should greatly contribute to enhanced bone formation (Moriishi et al. [@CR35]). However, bone formation is enhanced in trabecular bone and on the periosteal surface but not on the endocortical surface of cortical bone in *BCL2* transgenic mice (Moriishi et al. [@CR35]). Thus, the osteocyte network might send some positive signals to osteoblasts on the endocortical surface, in addition to the negative signal by Sost.

Regulation of bone mass by mechanical stress {#Sec5}
============================================

Application of mechanical stimuli to osteocytes in vitro induces the release of anabolic factors, such as prostaglandin E~2~, prostaglandin I~2~, nitric oxide, cyclooxygenase-2 and endothelial nitric oxide synthase (Burger and Klein-Nulend [@CR6]). Further, it is widely accepted that mechanical stress increases bone mass by enhancing bone formation and inhibiting bone resorption, whereas unloading reduces bone mass by inhibiting bone formation and enhancing bone resorption and that the osteocyte network is an appropriate system for the sensing apparatus (Burger and Klein-Nulend [@CR6]; Martin [@CR33]; Ehrlich and Lanyon [@CR12]; Knothe Tate [@CR20]; Noble [@CR40]; Bonewald and Johnson [@CR5]). However, difficulties have been experienced in establishing that the osteocyte network is responsible for the regulation of bone mass by mechanical stress, because osteocyte death provokes bone resorption.

Bone-specific *Gja1* conditional knockout mice, in which intercellular communication through gap junctions is disrupted, represent a potential mouse model for evaluating whether the osteocyte network acts as the mechanosensing apparatus. However, the responses to mechanical stress in the *Gja1* conditional knockout mice are variable. In the unloaded condition following hind limb muscle paralysis, bone resorption is enhanced on the endocortical surface of tibiae in wild-type mice but not in the conditional *Gja1* knockout mice, in which *Gja1* is deleted in osteoblasts and osteocytes using 2.3-kb Col1a1 promoter Cre transgenic mice (Grimston et al. [@CR15]). However, the finding that bone resorption on the endocortical surface of the conditional *Gja1* knockout mice is enhanced under physiological conditions makes the evaluation difficult. Two groups have reported the response to mechanical stress in *Gja1* conditional knockout mice, in which *Gja1* is deleted in mature osteoblasts and osteocytes using human osteocalcin promoter Cre transgenic mice. Zhang et al. ([@CR68]) have shown that periosteal bone formation is enhanced by mechanical loading in the conditional *Gja1* knockout mice but not in wild-type mice, whereas Lloyd et al. ([@CR28]) have demonstrated that bone formation on both endocortical and periosteal surfaces is decreased in wild-type mice but not in *Gja1* conditional knockout mice at unloading. As hemichannels and gap junctions, both of which are formed by Gja1, play important roles in the response to mechanical stress in osteocytes in vitro (Cherian et al. [@CR9]; Batra et al. [@CR2]), we need to evaluate the physiological importance of Gja1 in the response to mechanical stress by using osteocyte-specific *Gja1* conditional knockout mice.

In the unloaded condition, bone resorption is enhanced and bone formation is mildly suppressed in trabecular bone of wild-type mice but not of *BCL2* transgenic mice at 4 months of age, indicating that the osteocyte network is responsible for bone loss at unloading (Moriishi et al. [@CR35]). *Rankl* is upregulated in osteoblasts of wild-type mice but not of *BCL2* transgenic mice at unloading (Moriishi et al. [@CR35]). Therefore, the osteocyte network is required for the induction of *Rankl* in osteoblasts at unloading. Although *Rankl* upregulation in osteocytes in the unloaded condition might increase bone resorption by reducing Opg release from osteocytes to the bone surface, the upregulation of *Rankl* in osteocytes by unloading is inconsistently observed (Xiong et al. [@CR66]; Moriishi et al. [@CR35]).

The reduction in bone formation in response to unloading is abrogated in *Sost*^-/-^ mice and the level of *Sost* mRNA but not Sost-positive osteocytes is increased after unloading (Robling et al. [@CR48]; Lin et al. [@CR27]). Further, the downregulation of Sost after loading is dependent on the site in the tibiae (Moustafa et al. [@CR37]). In hind limb unloading by tail suspension, Sost-positive cells are regionally increased in wild-type mice but not in *BCL2* transgenic mice at 4 months of age (Moriishi et al. [@CR35]). Therefore, the osteocyte network is required for the upregulation of Sost expression at unloading, which is, at least in part, responsible for the reduction of bone formation in the unloaded condition.

Many other molecules, including PTH, estrogen receptor α, androgen receptor, leptin, periostin, β1 integrin and IL-11, are also involved in the response to mechanical loading (Price et al. [@CR45]). Loading above physiological conditions activates anabolic pathways and suppresses anti-anabolic pathways for bone formation and makes the overall function of osteocytes more anabolic. Recently, we have shown that the mRNA expression of pyruvate dehydrogenase kinase 4 (Pdk4), which inactivates the pyruvate dehydrogenase complex, is upregulated in osteoblasts and osteocytes in the unloaded condition in wild-type mice but not in *BCL2* transgenic mice at 4 months of age and that bone resorption is not enhanced in the unloaded condition in *Pdk4*-deficient mice. Thus, Pdk4 is involved in a catabolic pathway in the unloaded condition (Wang et al. [@CR61]).

Concluding remarks {#Sec6}
==================

Gene targeting experiments, especially the generation of osteocyte-specific conditional knockout mice, are revealing the importance of osteocytes in bone modeling and remodeling. Although these experiments have uncovered the function of individual genes in osteocytes, the overall function of the osteocyte network remains to be clarified, because osteocyte death causes apoptosis- or necrosis-induced bone resorption. Indeed, an ideal mouse model for the evaluation of the overall function of the osteocyte network seems to be an impossibility. Taking into consideration recent findings from osteocyte-network-disrupted mouse models with previous histological observations, however, the overall functions of the osteocyte network are now evident. The osteocyte network enhances bone resorption by activating osteoclastogenesis but inhibits bone formation by suppressing osteoblast function under physiological conditions. In the unloaded condition, the functions of the osteocyte network are augmented and bone resorption is further enhanced and bone formation is further inhibited. These functions of the osteocyte network also explain the increases in bone mass seen after exercise in many clinical studies (Schwab and Klein [@CR52]), because the osteocyte network decreases the inhibitory effects on bone mass by reducing the stimulatory effect on osteoclastogenesis and the inhibitory effect on osteoblast function in the loaded condition (under physiological conditions) compared with the unloaded condition.
